Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Basel Medical (BMGL) FCF Margin (2023 - 2024)

Historic FCF Margin for Basel Medical (BMGL) over the last 2 years, with Q4 2024 value amounting to 76.96%.

  • Basel Medical's FCF Margin fell 771100.0% to 76.96% in Q4 2024 from the same period last year, while for Jun 2025 it was 37.97%, marking a year-over-year change of. This contributed to the annual value of 37.3% for FY2025, which is 680600.0% down from last year.
  • Latest data reveals that Basel Medical reported FCF Margin of 76.96% as of Q4 2024, which was down 771100.0% from 0.16% recorded in Q4 2023.
  • In the past 5 years, Basel Medical's FCF Margin registered a high of 0.16% during Q4 2023, and its lowest value of 76.96% during Q4 2024.